Modelling HIV/AIDS epidemics in Botswana and India: Impact of interventions to prevent transmission

Bulletin of the World Health Organization

Volumn 80, Issue 2, 2002, Pages 89-96

  Nagelkerke, Nico J D ^a   Jha, Prabhat ^a   De Vlas, Sake J ^a   Korenromp, Eline L ^a   Moses, Stephen ^a   Blanchard, James F ^a   Plummer, Frank A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Botswana; Computer simulation; Disease outbreaks prevention and control; Disease transmission prevention and control prevention and control; HIV infections epidemiology prevention and control drug therapy; India (source: MeSH, NLM); Models, theoretical

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE PREVALENCE; DISEASE TRANSMISSION; EPIDEMIC; HUMAN IMMUNODEFICIENCY VIRUS; PROSTITUTION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIMICROBIAL THERAPY; ARTICLE; BEHAVIOR; BOTSWANA; DISEASE TRANSMISSION; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION CONTROL; MODEL; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BOTSWANA; COMMUNICABLE DISEASE CONTROL; COMPUTER SIMULATION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INDIA; INFANT, NEWBORN; MODELS, STATISTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGRAM EVALUATION; PROSTITUTION;

BOTSWANA; INDIA;

EID: 0036193458     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomised controlled trial
2. Control of sexually transmitted diseases for HIV-1 prevention: Understanding the implications of the Mwanza and Rakai trials
3. From Mwanza and Rakai to Beijing and Moscow? STD control and HIV prevention
4. Interventions to reduce mother-to-child transmission of HIV infection: New developments and current controversies
5. Advances and research directions in the prevention of mother-to-child HIV-1 transmission
6. Prevention of mother-to-child transmission of HIV in developing countries: Recommendations for practice
7. Antiviral therapy and the transmission dynamics of HIV-1
8. Notes on the socio-economic and cultural factors influencing the transmission of HIV in Botswana
9. Human immunodeficiency virus and migrant labor in South Africa
10. Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India
11. HIV and India: Looking into the abyss
12. Spread of HIV infection in married monogamous women in India
13. Overview and selected findings of sexual behaviour surveys
14. Sexual behaviour in developing countries: Implications for HIV control
15. Human immunodeficiency virus transmission among heterosexual couples in Central Africa
16. Sex worker, client sex behaviour and condom use in Harare, Zimbabwe
17. Sexual networks in Uganda: Casual and commercial sex in a trading town
18. Sexual behaviour in a fishing community on Lake Victoria, Uganda
19. Concurrent sexual partnerships and HIV prevalence in five urban communities of sub-Saharan Africa
20. Modelling the HIV/AIDS epidemic in India and Botswana: The effects of interventions. Internet communication, 23 November 2001
21. Reducing HIV transmission in developing countries
22. Controlling HIV in Africa: Effectiveness and cost of an intervention in a high-frequency STD transmitter core group
23. STD/HIV Intervention with sex workers in West Bengal, India
24. Impact of an intervention on HIV, sexually transmitted diseases, and condom use among CSW in Bombay, India
25. Beyond medical model of STD intervention - Lessons from Sonagachi
26. Estimating the magnitude of STD cofactor effects on HIV transmission - How well can it be done?
27. Preventing HIV-1: Lessons from Mwanza and Rakai
28. Preventing HIV-1: Lessons from Mwanza and Rakai
29. Preventing HIV-1: Lessons from Mwanza and Rakai
30. Preventing HIV infection: Lessons from Mwanza and Rakai
31. Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population
32. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda
33. Community-based trials of sexually transmitted disease treatment: Repercussions for epidemiology and disease prevention
34. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
35. Breastfeeding and HIV-1 infection. A review of current literature
36. Survival after diagnosis of AIDS among adults resident in the United Kingdom in the era of multiple therapies
37. Antiretroviral therapy and declining AIDS mortality in New York City
38. Limits to potent antiretroviral therapy
39. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study
40. Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy
41. Increases in unsafe sex and rectal gonorrhea among men who have sex with men - San Francisco, California, 1994-1997
42. Male circumcision: Assessment of health benefits and risks
43. Viral load and heterosexual transmission of human immunodeficiency virus type 1
44. Analysis of the scientific literature on male circumcision and risk for HIV infection
45. Epidemiologic evidence for time variation in HIV infectiousness
46. Community-based approaches to HIV treatment in resource-poor settings
47. Preventing antiretroviral anarchy in sub-Saharan Africa
48. The pandemic of antibiotic resistance
49. Multidrug-resistant tuberculosis and its control
50. More realistic models of sexually transmitted disease transmission dynamics: Sexual partnership networks, pair models, and moment closure
51. Focusing strategies of condom use against HIV in different behavioural settings: An evaluation based on a simulation model
52. STDSIM: A microsimulation model for decision support in STD control
53. Both a 'magic bullet' and good aim are required to link public health interests and health care needs in HIV infection
54. A tale of two futures: HIV and antiretroviral therapy in San Francisco
55. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus
56. Resistance to antiretroviral drugs in patients with primary HIV-1 infection
57. Antiretroviral drug resistance in HIV-1
58. Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998
59. Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel
60. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion
61. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
62. HIV-1 drug resistance in newly infected individuals
63. Transmission of antiretroviral-drug-resistant HIV-1 variants
64. The role of antiretrovirals and drug resistance in vertical transmission of HIV-1 infection
65. Projecting the impact of AIDS on mortality
66. Influence of mathematical modeling of HIV and AIDS on policies and programs in the developing world
67. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population
68. Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: The epidemic in India